Catalyst Wire Dossier Catalyst Wire Dossier

Minhai PCV13-DT/TT vaccine

PCV13-DT/TT conjugate vaccine · Beijing Minhai Biotechnology Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Minhai PCV13-DT/TT vaccine, covering 2025-03-24 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine [Phase 3]

See pricing